5-AZACYTIDINE FOR THE TREATMENT OF LOW/INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 63 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM

被引：0
|
作者：
Musto, P. [1 ]
Maurillo, L. [2 ]
Spagnoli, A.
Gozzini, A.
Rivellini, F.
Tatarelli, C.
Lunghi, M.
Fili, C.
Orciuolo, E.
Ciuffreda, L.
Vigna, E.
Della Cioppa, P.
Ferrero, D.
Palmieri, S.
Palumbo, G.
Di Renzo, N.
Oliva, E.
Sanpaolo, G.
Pastore, D.
Tonso, A.
Santagostino, A.
Villani, O.
D'Auria, F.
D'Arco, A.
Gaidano, G.
Galimberti, S.
Russo, D.
Venditti, A.
Aloe-Spiriti, M. A.
Leone, G.
Santini, V.
机构：
[1] CROB, Rionero In Vulture, PZ, Italy
[2] Univ Roma Tor Vergata, S Eugenio Hosp, Rome, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0925
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [1] 5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program
    Musto, Luca Maurillo
    Spagnoli, Alessandra
    Gozzini, Antonella
    Rivellini, Flavia
    Tatarelli, Caterina
    Lunghi, Monia
    Fili, Carla
    Orciuolo, Enrico
    Ciuffreda, Lucia
    Vigna, Ernesto
    Della Cioppa, Paola
    Candoni, Anna
    Ferrero, Dario
    Palmieri, Salvatore
    Palumbo, Giuseppe
    Di Renzo, Nicola
    Oliva, Esther
    Sanpaolo, Grazia
    Pastore, Domenico
    Tonso, Anna
    Santagostino, Alberto
    Rocco, Stefano
    Villani, Oreste
    D'Auria, Fiorella
    D'Arco, Alfonso Maria
    Gaidano, Gianluca
    Galimberti, Sara
    Russo, Domenico
    Venditti, Adriano
    Aloe-Spiriti, Maria Antonietta
    Leone, Giuseppe
    Santini, Valeria
    [J]. BLOOD, 2008, 112 (11) : 926 - 927
  • [2] 5-AZACYTIDINE FOR THE TREATMENT OF INTERMEDIATE-2/HIGH IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 83 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
    Maurillo, L.
    Spagnoli, A.
    Gozzini, A.
    Cecconi, N.
    D'Argenio, M.
    Lunghi, M.
    Rocco, S.
    Palumbo, G.
    Rivellini, E.
    Genuardi, M.
    Sibilla, S.
    Ferrara, F.
    Mele, G.
    Filardi, N.
    Sanpaolo, G.
    Specchia, G.
    Tonso, A.
    Santagostino, A.
    Voso, M. T.
    Balleari, E.
    Cassibba, V.
    Della Cioppa, P.
    Mazzone, C.
    Oliva, E.
    Ciuffreda, L.
    Russo, D.
    Galimberti, S.
    Villani, O.
    D'Auria, F.
    Di Renzo, N.
    D'Arco, A. M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 96 - 96
  • [3] ELTROMBOPAG FOR THE TREATMENT OF THROMBOCYTOPENIA OF LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A PROSPECTIVE, RANDOMIZED, TRIAL
    Oliva, E.
    Santini, V.
    Zini, G.
    Palumbo, G.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M.
    Molteni, A.
    Sanpaolo, G.
    Liberati, A.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M.
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Raimondo, F.
    Leoni, P.
    Alimena, G.
    Fioritoni, G.
    Latagliata, R.
    Nobile, F.
    [J]. HAEMATOLOGICA, 2013, 98 : 456 - 456
  • [4] Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: Results of a prospective, randomized trial
    Oliva, E. N.
    Santini, V.
    Zini, G.
    Palumbo, G. A.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M. T.
    Molteni, A.
    Sanpaolo, G.
    Liberati, M.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M. A. Aloe
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Di Raimondo, F.
    Leoni, P.
    Alimena, G.
    Latagliata, R.
    Nobile, F.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S162 - S162
  • [5] 5-AZACYTIDINE FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA: RESULTS IN 45 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
    Musto, P.
    Maurillo, L.
    Spagnoli, A.
    Genuardi, M.
    Lunghi, M.
    Di Renzo, N.
    Mele, G.
    Levis, A.
    D'Arco, A.
    Gozzini, A.
    Petrini, M.
    Mianulli, M.
    Sanpaolo, G.
    Santagostino, A.
    Pietrantuono, G.
    D'Auria, E.
    Ferrero, D.
    Gaidano, G.
    Ferrara, E.
    Santini, V.
    Leone, G.
    Bosi, A.
    Venditti, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 93 - 93
  • [6] Azacitidine for the treatment of lower risk myelodysplastic syndromes: final results from an Italian named patient program
    Musto, P.
    Maurillo, L.
    Spagnoli, A.
    D'Arco, A.
    Pollio, B.
    Candoni, A.
    Spiriti, A. Aloe
    Lunghi, M.
    Fili, C.
    Orciuolo, E.
    Venditti, A.
    Morabito, F.
    Mazza, P.
    Pastore, D.
    Santini, V.
    [J]. LEUKEMIA RESEARCH, 2009, 33 : S127 - S127
  • [7] OUTCOMES OF CONTINUED AZACITIDINE TREATMENT FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME IN IPSS LOW AND INTERMEDIATE-1
    Moon, J. H.
    Sohn, S. K.
    Cho, Y. Y.
    Kim, Y. K.
    Kim, H. J.
    Kim, M. K.
    Do, Y. R.
    Song, M. K.
    Lee, W. K.
    Lee, S. M.
    Kim, H.
    Won, J. H.
    Yeon, J. Deok
    [J]. HAEMATOLOGICA, 2012, 97 : 141 - 141
  • [8] Treatment of Anemia with Darbepoetin Alfa in Patients with Low and Intermediate-1 Risk Myelodysplastic Syndromes. Results from the ARAMYS Study
    Villegas, Ana
    Arrizabalaga, B.
    Fernandez-lago, C.
    Mouzo, M.
    Mayans, Jr
    Gonalez-Porras, Jr
    Duarte, Rafael
    Remacha, Angel Francisco
    Luno, Elisa
    Gasquet, J. A.
    [J]. BLOOD, 2008, 112 (11) : 1184 - 1184
  • [9] Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes
    Garcia-Manero, Guillermo
    Diez-Campelo, Maria
    Vellenga, Edo
    Jacoby, Meagan A.
    Merchan, Brayan
    Breems, Dimitri
    Cortelezzi, Agostino
    Doronin, Vadim
    Gomez, Valle
    Beckers, Marielle
    Della Porta, Matteo Giovanni
    Varsos, Helen
    Xiu, Liang
    DeAngelis, Nikki
    Nnane, Ivo
    Rose, Esther
    van Eygen, Koen
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (04) : E111 - E114
  • [10] Diagnostic procedures and treatment of patients with Myelodysplastic Syndromes (MDS) of low and intermediate-1 risk. Results of the outpatient MDS registry
    Schmitz, S.
    Boettger, I
    Schnell, R.
    Lerchenmueller, C.
    Sauer, A.
    Severin, K.
    Germing, U.
    Steinmetz, H. T.
    [J]. ONKOLOGIE, 2012, 35 : 148 - 148
12345